As of today (2024-05-07), the Trailing Annual Dividend Yield of Generex Biotechnology is 0.00%.
The historical rank and industry rank for Generex Biotechnology's Dividend Yield % or its related term are showing as below:
GNBTQ's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.44 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Generex Biotechnology Dividend Yield % Historical Data
The historical data trend for Generex Biotechnology's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Generex Biotechnology's Dividend Yield %
For the Biotechnology subindustry, Generex Biotechnology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generex Biotechnology's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Generex Biotechnology's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Generex Biotechnology's Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Generex Biotechnology Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Generex Biotechnology's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Generex Biotechnology (Generex Biotechnology) Business Description
Generex Biotechnology Corp is a Biotechnology company which is primarily engaged in the research and development of drug delivery systems and technologies. It mainly focuses on developing technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a hand-held aerosol applicator. The company operates in the single segment being the Research and development of drug delivery systems and technologies for metabolic and immunological diseases. In addition, the company engages in developing proprietary vaccine formulations through its subsidiaries that work by stimulating the immune system to either attack offending agents that is cancer cells, bacteria, and viruses or to stop attacking benign elements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GNBTQ has been successfully added to your 